Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

NeuroBytes: A new rapid, high-yield, nationwide e-Learning platform for continuing professional development in neurology
Research Methodology, Âé¶¹´«Ã½Ó³»­, and History
P4 - Poster Session 4 (5:30 PM-6:30 PM)
6-004

To assess the feasibility, usability, audience, and effectiveness of NeuroBytes, an asynchronous e-Learning program.

In an effort to offer continuing professional development (CPD) updates to a wide range of professionals, the Âé¶¹´«Ã½Ó³»­ launched NeuroBytes– bite-sized videos that provide topic-specific updates.

NeuroBytes was beta tested August–December 2018 and launched for pilot circulation January–April 2019. Usage was assessed by course enrollment and completion rates; feasibility by cost and time required per module; appeal by user satisfaction scores; effectiveness by self-reported change in practice.

A total of 5,130 member enrollments (1,026+551/month) occurred from January 11–May 28, 2019 with a median of 588 enrollments per module (range, 194-922) and 37% course completion. The majority of viewers included neurologists (54%) and junior neurologists (26%). NeuroBytes took 59 hours to develop ($77.94/hour). 82% of users were “extremely” or “very” likely to recommend NeuroBytes, 60% agreed that the depth of content was “just right,” and 29% responded NeuroBytes would change how they managed many of their patients.

NeuroBytes is a user-friendly CPD product that delivers updates to a broad range of learners. Complementary programs are needed to change practice patterns and future efforts will integrate NeuroBytes into the spectrum of CPD programs.

Authors/Disclosures
Laura E. Lavette (Wake Forest School of Medicine)
PRESENTER
No disclosure on file
Alexandra M. Miller, MD (NYU Langone Department of Neurology) Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Modifi Biosciences.
Robert A. Rook (Âé¶¹´«Ã½Ó³»­) Mr. Rook has nothing to disclose.
Zachary N. London, MD, FÂé¶¹´«Ã½Ó³»­ (University of Michigan) Dr. London has nothing to disclose.
Calli L. Cook, DNP, FNP-C, DÂé¶¹´«Ã½Ó³»­, FÂé¶¹´«Ã½Ó³»­ (Emory Healthcare) Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Alexander Merkler, MD Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Veronica E. Santini, MD, MA, FÂé¶¹´«Ã½Ó³»­ Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion NeuroStim, Inc. The institution of Dr. Santini has received research support from MeiraGTx, LLC. The institution of Dr. Santini has received research support from Ono Pharmaceuticals. The institution of Dr. Santini has received research support from Lundbeck. The institution of Dr. Santini has received research support from American Parkinson Disease Association. The institution of Dr. Santini has received research support from Mission MSA. The institution of Dr. Santini has received research support from CurePSP. The institution of Dr. Santini has received research support from Parkinson Foundation. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with Âé¶¹´«Ã½Ó³»­. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with International Parkinson and Movement Disorders Society. Dr. Santini has received personal compensation in the range of $0-$499 for serving as a invited speaker with Parkinson Study Group. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a data safety monitoring board with NIH.
Ilana M. Ruff, MD Dr. Ruff has nothing to disclose.
Jeff Kraakevik, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Don B. Smith, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Âé¶¹´«Ã½Ó³»­.
Wayne E. Anderson, DO, FÂé¶¹´«Ã½Ó³»­ An immediate family member of Dr. Anderson has received personal compensation for serving as an employee of Gilead Sciences. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for occasional claims.
Stacy L. Johnson, NP (Fort Wayne Neurological Center) Ms. Johnson has nothing to disclose.
Peter Z. Yan, MD, MS (Beth Israel Deaconess Hospital - Milton) Dr. Yan has nothing to disclose.
Joan Sweeney, MD Dr. Sweeney has nothing to disclose.
Amanda Chamberlain (Âé¶¹´«Ã½Ó³»­) No disclosure on file
Beth Rogers-Baggett (Âé¶¹´«Ã½Ó³»­) No disclosure on file
Richard S. Isaacson, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Roy E. Strowd III, MD, FÂé¶¹´«Ã½Ó³»­ (Wake Forest School Of Medicine) Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Âé¶¹´«Ã½Ó³»­. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.